Profile
Daniel J.
Cushing formerly worked at Pfizer Inc., as Principal, AstraZeneca PLC, as Principal, Prism Pharmaceuticals, Inc., as Chief Scientific Officer & VP-Regulatory Affairs, Merck Research Laboratories Massachusetts LLC, as Principal, Nuron Biotech, Inc., as Senior Vice President-Research & Development, and Carisma Therapeutics, Inc., as Chief Technology & Development Officer from 2017 to 2024.
Former positions of Daniel Cushing
| Companies | Position | End |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2024 |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Chief Tech/Sci/R&D Officer | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Prism Pharmaceuticals, Inc.
Prism Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cardiovascular injectibles and pharmaceutical products | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
Carisma Therapeutics, Inc.
Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
- Stock Market
- Insiders
- Daniel Cushing
















